Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Targeting The Wasf3 Regulatory Complex In Pancreatic Cancer Using Stapled Peptides.
  1. Home
  3. Targeting The Wasf3 Regulatory Complex In Pancreatic Cancer Using Stapled Peptides.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anionic lipids direct efficient microfluidic encapsulation of stable and functionally active proteins in lipid nanoparticles.

Communications materials·2025
Same author

Development of an All-Hydrocarbon Stapled Peptide Targeting BRK1 in Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2025
Same author

Targeted Degradation of Protein Kinase A via a Stapled Peptide PROTAC.

ACS chemical biology·2024
Same author

Targeting Rab-RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's disease.

Journal of peptide science : an official publication of the European Peptide Society·2023
Same author

Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization.

ACS chemical neuroscience·2023
Same author

<i>In Silico</i> Optimized Stapled Peptides Targeting WASF3 in Breast Cancer.

ACS medicinal chemistry letters·2022
Same journal

Nature's Anaerobic Toolkit: Glycyl Radical Enzymes and Their Expanding Functional and Mechanistic Diversity.

Biochemistry·2026
Same journal

Structural Bases for the Unconventional Activity of a Viroporin Channel.

Biochemistry·2026
Same journal

Thermodynamic and Allosteric Drivers of Stilbene-Mediated Noncompetitive Inhibition of Firefly Luciferase.

Biochemistry·2026
Same journal

Gut Bacterial 20-Hydroxysteroid Dehydrogenases Modify Endogenous Glucocorticoids and Corticosteroid Drugs.

Biochemistry·2026
Same journal

Single-Residue Mutation Switch Reconfigures the Hierarchical Structure and Assembly of Amphiphilic Protein Block Copolymers for Hydration Layer-Dominated Water-Responsive Actuation.

Biochemistry·2026
Same journal

A Thymine Dimer Stalls a High-Fidelity DNA Polymerase by Providing No Template Information in the Same Manner as an Abasic Site.

Biochemistry·2026
See all related articles

Related Experiment Video

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

Targeting the WASF3 Regulatory Complex in Pancreatic Cancer Using Stapled Peptides.

Taylor C Dill1, Elliot J Alger2, Sophia Gambale2

  • 1Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

Biochemistry
|June 24, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

A novel peptide, WAHM1, disrupts the WASF Regulatory Complex (WRC) in pancreatic cancer cells. This disruption suppresses tumor cell invasion and migration, offering a potential new therapeutic strategy.

Related Experiment Videos

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Wiskott-Aldrich Syndrome Protein Family (WASF) members, including WASF3, are crucial for actin cytoskeletal remodeling.
  • Elevated WASF3 expression in pancreatic cancer correlates with poor prognosis, increased invasion, and metastasis.
  • The WASF Regulatory Complex (WRC) is a key regulator of WASF protein function.

Purpose of the Study:

  • To investigate if disrupting the WRC can inhibit WASF3-driven actin polymerization, cellular invasion, and motility in pancreatic cancer.
  • To identify specific molecular strategies targeting the WRC for therapeutic intervention in pancreatic cancer.

Main Methods:

  • Screening of constrained peptides designed to interfere with WRC protein-protein interactions.
  • Evaluation of peptide efficacy in suppressing pancreatic cancer cell lines (PANC-1, BxPC-3).
  • Assessment of peptide cellular permeability, target binding, and WRC protein level reduction.

Main Results:

  • A WASF3-derived peptide, WAHM1, effectively suppressed pancreatic cancer cell motility and invasion.
  • WAHM1 demonstrated cellular permeability and specific binding to WRC targets within pancreatic cancer cells.
  • Treatment with WAHM1 led to a reduction in WRC protein levels.

Conclusions:

  • Disruption of the WRC using the peptide WAHM1 is a viable strategy to inhibit pancreatic cancer cell invasion and migration.
  • WAHM1 shows promise as a potential therapeutic agent to downregulate WASF3-mediated processes in pancreatic cancer.
  • Targeting the WRC represents a novel approach for developing complementary therapies for pancreatic cancer.